Q-Day: A Present-Day FDA Compliance Gap
The FDA's February 2026 premarket guidance requires cryptography that stays strong throughout a device's service life. Q-Day exposes a real compliance gap.
Read articleEvery article in our archive tagged Primer.
Showing 12 of 120 articles tagged Primer · Page 3 of 10
The FDA's February 2026 premarket guidance requires cryptography that stays strong throughout a device's service life. Q-Day exposes a real compliance gap.
Read article
How the FDA is using Form 483 observations to cite cybersecurity gaps under QMSR and 21 CFR 820, with recent examples and how manufacturers should respond.
Read article
SBOM vs VEX explained for medical device submissions. What each document does, how they pair, and what the FDA actually expects in your 510(k) package.
Read article
Avoid common VEX mistakes that trigger FDA cybersecurity deficiencies. Learn to properly prepare your VEX for medical device premarket submissions.
Read article
FDA Deficiency Letter, RTA, and Hold Letter explained side-by-side. What each one means, the clock impact, and how to respond without losing months.
Read article
Medical device cybersecurity fundamentally differs from enterprise IT due to patient safety, FDA regulations, and unique technical constraints. Learn why.
Read article
Postmarket medical device cybersecurity is a shared responsibility. See how manufacturers & healthcare organizations must collaborate to reduce. Aligned with.
Read article
NeuroTech cybersecurity risks affect therapy and neural data. Learn threats, controls, and FDA-ready documentation for neurostimulators, EEG, and BCI.
Read article
Learn how to get medical device cybersecurity labeling right with MDS2, JSP2, and FDA expectations - improving transparency, accountability, and patient.
Read article
How MedTech teams combine market intelligence and cybersecurity to accelerate growth, de-risk FDA submissions, and win enterprise health-system deals.
Read article
MedTech Cybersecurity Insights for Innovators: a practical 2026 playbook for MedTech leaders, what to prioritize, how the FDA expects it framed, and where teams stumble.
Read article
Learn the difference between SaMD and SiMD, why it matters for FDA strategy, and how to build secure-by-design medical devices across your product.
Read article30-minute strategy session. No cost, no commitment - just answers from people who've shipped 250+ FDA submissions.